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Abstract.  We have raised two monospecific antibodies 
against synthetic peptides derived from the membrane 
domain of the ER glycoprotein 3-hydroxy-3-methylglu- 
taryl coenzyme A  (HMG-CoA) reductase, the rate 
limiting enzyme in the cholesterol biosynthetic path- 
way. This domain, which was proposed to span the 
ER membrane seven times (Liscum, L., J.  Finer- 
Moore, R.  M.  Stroud, K.  L. Luskey, M.  S. Brown, 
and J.  L. Goldstein.  1985. J.  Biol.  Chem. 260:522- 
538), plays a critical role in the regulated degradation 
of the enzyme in the ER in response to sterols. The 
antibodies stain the ER of cells and immunoprecipitate 
HMG-CoA reductase and HMGal, a chimeric protein 
composed of the membrane domain of the reductase 
fused to Escherichia  coli/3-galactosidase,  the degrada- 
tion of which is also accelerated by sterols. We show 
that the sequence Arg  TM through Leu  242 of HMG-CoA 
reductase (peptide G) faces the cytoplasm both in cul- 
tured cells and in rat liver, whereas the sequence 
Thr  TM through Glu  m  (peptide H) faces the lumen of 
the ER.  This indicates that a sequence between pep- 
tide G and peptide H  spans the membrane of the ER. 
Moreover, by epitope tagging with peptide H,  we 
show that the loop segment connecting membrane 
spans 3 and 4  is sequestered in the lumen of the ER. 
These results demonstrate that the membrane domain 
of HMG-CoA reductase spans the ER eight times and 
are inconsistent with the seven membrane spans topo- 
logical model. The approximate boundaries of the pro- 
posed additional transmembrane segment are between 
Lys  24s and Asp  276. Replacement of this 7th span in 
HMGal with the first transmembrane helix of bacterio- 
rhodopsin abolishes the sterol-enhanced degradation of 
the protein, indicating its role in the regulated turn- 
over of HMG-CoA reductase within the endoplasmic 
reticulum. 
3-HYDROXY-3-METHYLGLUTARYL coenzyme A  (HMG- 
CoA)  t reductase catalyzes the conversion of HMG-CoA to 
mevalonate (Durr and Rudney, 1960), the precursor for a 
wide variety of metabolites that play central roles in cellular 
functions.  These products of the mevalonate pathway in- 
clude sterols,  ubiquinone,  dolichols,  isopentenyladenine, 
heme A and the isoprenyl moieties of proteins (for a recent 
review see Goldstein  and Brown,  1990). In mammalian 
cells, HMG-CoA reductase is the major regulatory enzyme 
in this pathway and is subject to complex metabolic control 
ensuring an adequate supply of intermediates and products 
of this pathway. This is achieved by regulation of transcrip- 
tion of  the HMG-CoA reductase gene (Liscum et al., 1983a; 
Osborne et al., 1985), regulation of translation of its mRNA 
(Tanaka et al., 1983; Petfley and Sinensky, 1985; Nakanishi 
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et al., 1988), controlled degradation of the reductase protein 
(Sinensky and Logel, 1983; Edwards et al., 1983; Gil et al., 
1985; Chin et al., 1985), and modulation of enzyme activity 
(Hardie et al.,  1989; Roitelman and Shechter,  1984). 
Through cloning  of its cDNA, the primary structure of 
HMG-CoA  reductase  from  many  eukaryotes,  including 
yeast (Basson et al., 1988), plants (Learned and Fink, 1989; 
Caelles et al., 1989), fly (Gertler et al., 1988), schistosomes 
(Rajkovic et al., 1989), sea urchin (Woodward et al., 1988), 
frog (Chen and Shapiro,  1990), rodents (Chin et al., 1984; 
Skalnik  and  Simoni,  1985), and  humans  (Luskey  and 
Stevens,  1985) has been deduced. Mammalian HMG-CoA 
reductase is a 97-kD membrane-bound "high mannose" gly- 
coprotein of the ER  (Liscum et al.,  1983b; Brown  and 
Simoni,  1984). The enzyme is co-translationally  inserted 
into  the ER  membrane in  a  signal  recognition particle- 
dependent manner (Brown and Simoni,  1984), and it lacks 
a cleavable signal sequence (Brown and Simoni,  1984; Chin 
et al., 1984). Under certain conditions, the enzyme appears 
to function as a homodimer (Edwards et al., 1985; Ness et 
al., 1985; Roitelman and Shechter, 1986). The catalytic site, 
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peptide chain,  faces the cytoplasm (Liscum et al.,  1983b, 
1985), where the soluble substrates are found. Not surpris- 
ingly, the catalytic domain of the enzyme displays a high de- 
gree of homology among species. 
The  NH2-terminal  one-third  of  eukaryotic  HMG-CoA 
reductase,  which lacks any catalytic  activity is,  however, 
also homologous among many species (with the exception of 
yeast, plants, and schistosomes). This hydrophobic domain 
of the protein, which bears the carbohydrate moiety, anchors 
the reductase in the ER membrane (Liscum et al.,  1983b, 
Chin et al.,  1984; Brown and Simoni, 1984; Liscum et al., 
1985).  Moreover,  the  membrane  domain  of  HMG-CoA 
reductase,  when fused to Escherichia coli t3-galactosidase, 
is necessary and sufficient to confer ER localization  onto the 
chimeric HMGai protein (Skalnik et al., 1988; Chun et ai., 
1990). 
HMG-CoA reductase belongs to a class of proteins which 
are degraded in a pre-Golgi compartment,  probably within 
the ER, and includes individual subunits of oligomeric com- 
plexes or abnormal  proteins  (reviewed  by Bonifacino and 
Lippincott-Schwartz,  1991).  This novel process appears to 
constitute  a  cellular  mechanism  for  "quality control"  of 
newly synthesized proteins which are destined to exit the ER 
(Klansner and Sitia, 1990). For most proteins, the ER degra- 
dation is rapid and does not appear to be regulated.  The 
degradation of HMG-CoA reductase, which exhibits some of 
the characteristics  of the ER degradative pathway (Chun et 
al., 1990; Inoue et al., 1991), is unique in that the reductase 
is a normal resident ER protein and that the rate with which 
its degradation proceeds is dictated by the cellular needs for 
sterols and/or other metabolites of the mevalonate pathway. 
Although much has been learned  about the general  ar- 
chitecture  of HMG-CoA reductase,  the secondary  and ter- 
tiary structures of the protein remain unknown. Therefore, 
studying the structure of HMG-CoA reductase  is of prime 
importance to gain insight  into the structural basis under- 
lying its function. It has been demonstrated  that the mem- 
brane-bound  domain of HMG-CoA reductase  is necessary 
and sufficient  for the regulated degradation  of the enzyme 
(Gil et al.,  1985; Skalnik et al.,  1988; Chun et al.,  1990). 
Based on limited proteolysis and hydropathy plot analyses of 
its  deduced primary  structure,  Liscum et al.  proposed a 
topological model in which the NH2-terminal  340 amino 
acids of HMG-CoA reductase span the ER membrane seven 
times (Liscum et al., 1985). We have recently provided evi- 
dence  indicating  that HMG-CoA  reductase  spans the ER 
membrane eight times.  This was based on experiments  in 
which the insertion of mutant versions of HMG-CoA reduc- 
tase into ER vesicles was studied in vitro and on the in vivo 
glycosylation pattern of mutants of HMGal with engineered 
glycosylation sites (0lender and Simoni,  1992). In this re- 
port we provide immunological evidence for the additional 
membrane-spanning  segment.  Moreover,  we show that re- 
placing this segment with the first transmembrane  span of 
bacteriorhodopsin  eliminates the sterol-accelerated  degra- 
dation of HMG-CoA reductase. 
Materials and Methods 
Materials 
l~ptides were custom-synthesized by Multiple Peptide System (San Diego, 
CA.) Tuberculin  Purified Protein  Derivative (PPD)  was purchased  from 
Statens Seruminstitut (Copenhagen,  Denmark).  Complete and incomplete 
Freund's adjuvant and rhodamine-conjugated goat anti-mouse IgG were ob- 
tained  from Cappel  Organon  Teknika  Corp.  (West Chester,  PA). IgG 
purification kit was from Pierce Chemical Co,  (Rockford, IL).  Immuno- 
globulin detection  kit was purchased  from HyCIone (Logan,  UT). Goat 
anti-rabbit IgG conjugated to 5-rim colloidal gold was from Janssen Phar- 
maceutica  (piseataway,  NJ).  Glutaraldehyde,  mevalonate,  digitonin, 
cholcstyramine,  and FITC-labeled goat anti-rabbit IgG were from Sigma 
Chemical  Co.  (St.  Louis,  MO).  Cholesterol  was  from  Boehriager- 
Mannheim  Biochemicais  (Indianapolis,  IN).  25-hydroxycholesterot  was 
purchased from Steraloids Inc. (Wilton, NH). Streptolysin O (SLO) was ob- 
tained from Wellcome Diagnostics (Darfford, England).  1,4-diazobieyclo- 
[2.2.2J-octane  was from Aldrich  Chemical  Co.  (Milwaukee,  IL).  [35S]- 
mcthionine (sp. act. > 1,000 Ci/mmol) and oligonucleotide-directed in vitro 
mutagenesis  kit  were  from  Amersham  Corp.  (Arlington  Heights,  IL). 
pTZ18R phagemid was from Pharmacia LKB Biotechnology Inc. (piscata- 
way, NJ). Protein A Bacterial Adsorbent, Tran3SS-label metabolic labeling 
reagent (sp. act. > 1,000 Ci/mmol) and mouse anti-B-tubulin mAb (TUB2.1) 
were from ICN Biomedicals (Irvine, CA). Mouse anti-B-galaetosidase mAb 
was purchased from Promega (Madison, WI) and rabbit anti/~-galactosidase 
polyclonal antibodies were from 5 prime -> 3 prime, Inc. (Boulder, CO.). 
Oligonucleotides, synthesized on a DNA synthesizer (model 380B; Applied 
Biosystems,  Foster City, CA) in the Department  of Biological Sciences, 
Stanford University (Stanford, CA) were purified on OPC columns. Com- 
pactin was a gift from Akira Endo (Tokyo-Noko University, Tokyo, Japan). 
Rabbit polyclonal  antibodies  against the catalytic  domain  of HMG-CoA 
reductase were kindly provided by Hans-Stephan Jenke, (Institute ftir Zell- 
chemic, Miinchen, Federal Republic of Germany). Anti HMG-CoA reduc- 
tase mAb (A9) was a generous gift from Y. K.  Ho (University of Texas 
Health Science Center, Dallas, TX). 
Ce//s 
CHO cells expressing the HMGal fusion protein (CHO-HMGal)  (Skalnik 
et al.,  1988; Chun et al.,  1990) or the Span7-HMGal mutant  (Chun and 
Simoni,  1992) were maintained in MEM supplemented with 5% FCS and 
250 t~g/ml Geneticin. Elevated levels of HMG-CoA reductase and HMGal 
were induced by switching the cells to MEM supplemented with 5 % lipid- 
poor serum (Rothblat et aL,  1976) and  1 /~M compactin  and  100 #M 
mevalonate (Induction Medium; Chun et al., 1990; Roitelman et al., 1991). 
C100, an SV-40-transformed BHK cell line adapted to grow in the presence 
of 225 I~M compactin (Hardeman et al.,  1983), was maintained  in MEM 
supplemented with 5 % lipid-poor serum and 64 I~M compactin. COS cells 
were maintained in DME supplemented with 5 % FCS. 
Generation of  Anti-Peptide Antibodies 
The dry peptides,  synthesized with an extra  NH2-termimd lysine,  were 
directly dissolved at 1 mg/ml in PPD, which is supplied by the manufacturer 
as a 1 mg/mi solution in PBS. The relative molecular weight of the protein 
component in PPD is about t0,000 (Lachmann et al., 1986), therefore the 
molar ratio between a 20-residue long peptide and the carrier protein is ~5. 
Glutaraldehyde  was added to a final concentration  of 0.1% (vol/vol), and 
the mixture was stirred overnight at room temperature. Aliquots of the mix- 
ture were acetone precipitated,  PPD conjugates were collected by centrifu- 
gation, dried under reduced pressure,  redissolved in PBS at 1 nag/nil, and 
kept frozen at  -20~  until use. 
New Zealand White rabbits were first immunized by intramuscular injec- 
tion of 250 pg of PPD-coupted pcptides emulsified in complete Freund's ad- 
juvant. Rabbits were subsequently injected with 500 t~g of  coupled peptides, 
emulsified in incomplete Freund's adjuvant, at 4-wk intervals. Two rabbits 
were immunized with each peptide, blood was collected from the ear vein, 
and sera were prepared  and pooled.  The serum was tested by ELISA for 
anti-peptidr  antibodies one week after each injection. IgG fractions were 
purified on Agarose-Protein  A columns (Pierce Chemical Co.) according 
to the manufacturer's protocol. 
Metabolic Labeling and Immunoprecipitation 
Cells  were metabolically  labeled  with [35S]methionine  or Tran35S-label, 
and  HMG-CoA  reductase  and  HMGal were  immunoprecipitated,  as  previ- 
ously  described  (Chun et  al.,  1990). 
Indirect Immunofluorescence 
Cells were grown on 12-ram glass coverslips in 24-well cell culture dishes. 
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as described above.  Cells were washed twice in  PBS  and fixed in 2 % 
(wt/vol) paraformaldehyde in PBS for 15 min at room temperature. Excess 
paraformaldehyde was neutralized with 100 mM NI-14CI for 10 min, and 
the cells were further washed three times with PBS. Selective permeabiliza- 
tion of the plasma membrane was achieved by one of the following pro- 
tocols: (a) 15 min on ice with 10 #g/nil digitonin in 0.3 M sucrose/0.1  M 
KC1/2.5 mM MgCI2/1 mM EDTA/10 mM Pipes, pH 6.8; (b) 15 min on ice 
with 10 U/ml of SLO in PBS/2 mM DTT.  The SLO solution was then re- 
moved and cells were incubated in fresh PBS at 37~  for an additional 10 
min;  (c) semi-intact cells prepared by the nitrocellulose overlay method 
(Beckers et al.,  1987;  see below). Complete permeabilizatinn of cellular 
membranes of fixed cells was by treatment with 0.25% Triton X-IO0 in PBS 
for 5 rain on ice. After permeabilization by either protocol, the cells were 
washed three times with PBS and incubated with 5% BSA in PBS for 1 h 
at room temperature. The blocking solution was removed and fresh BSA 
solutions containing primary antibodies, at the appropriate dilution, were 
added and allowed to incubate at room temperature for 1 h. The cells were 
washed three times in 0.5 % BSA/PBS, and fluorescent secondary antibodies 
were added in 5% BSA/PBS for 2 h. After three washes in 0.5% BSA/PBS 
and an additional three times in PBS, the coverslips were rinsed in H20 
and mounted on glass slides in a drop of mounting solution (25 mg/ml of 
1,4-diazobicyclo[2.2.2]-octane in 90% glycerol/0.1  M Tris-Cl, pH 9; John- 
son et al., 1982). Cells were viewed and photographed in a Zeiss epifluores- 
cence microscope (Carl Zeiss, Oberkochen, Germany). 
Semi-intact  Cells 
The medium of CHO-HMGal cells, grown as a monolayer in 30 mm dishes, 
was aspirated and circles of nitrocellulose, pre-wetted in PBS, and blotted 
between sheets of Whatman paper for 5 s under a pressure of about 1 kg, 
were overlaid on top of the monolayer for 60 s. The nitrocellulose was then 
gently lifted from the monolayer and the cells were processed for im- 
munofluorescence analysis, as described above. For microscopy, a drop of 
mounting glycerol solution was added to the dish and a glass coverslip was 
placed on top of the monolayer. Cells were viewed while on the dish. 
Construction of  HMGal/Dins(A ) 
HMGai/Dins(A)  is  a  mutant of HMGal  in  which the  sequence His  26s 
through Glu  3~  (overlapping the H epitope and the native glycosylation site 
of HMG-CoA reductase) has been moved from its native position into the 
D loop segment connecting the putative 3rd and 4th membrane spans (Lis- 
cure et al., 1985) of HMG-CoA reductase (i.e., in between residues Thr 119 
and Glum23; see Figs.  1 and 8).  This mutant was constructed as follows: 
the  EcoR1/Pstl  DNA  fragment  of  pSRa-HMGal  (HMGal  cloned  in 
pcDLSRa296 (Takebe  et al.,  1988);  Chun and Simoni, 1992),  which en- 
codes the  entire  membrane  domain of HMG-CoA  reductase  (residues 
1-449), was subeloned into the muitifunctional phagemid pTZ18R to yield 
pTZ-HM.  Through  site-directed mutagenesis,  a  unique  Nhel  site  (un- 
derlined) was created after Thr Hg,  using the mutagehic oligonncleotide 
5'-AAAGAACTGACA~TAGCTGAAGCTTTGCCC-3'.  The native H 
epitope (the sequence Thr  TM through Glu  3ez) was destroyed by site-directed 
deletion  using  the  36mer  5'-TCCCCTCAGAACAGCACA/CCAAGTGT- 
TTCTCTCTGG-3' (where / indicates the site of deletion), bridging Thr  ~s3 
and pro303. The mutated membrane domain was swapped, as an EcoR1-Pstl 
fragment, with the wild-type membrane domain back into pSRaHMGal, 
creating pSRotHMGal(NheAH). A DNA which includes the sequence en- 
coding His  26s through Glu  3~  was generated by annealing four oligonucleo- 
tides comprising tva~ self-complementary sets (underlined nucleotides de- 
note Nhel overhangs): 5'-CTAGC~TCTAGACATGCTCACAGTCGCTGG- 
ATAGCTGATCCTTCCCCTCAG-3'  and 3'-CCAGATCTGTACGAGTGTC- 
AGCGACCTATCGACTAGGAA~AGTCTTGTCGTGT-5' and 5'-AA- 
CAGCACAACAGAACATTG TAAAGTTTC C TTGC~AC TAGATGAAGAT- 
GTGTCCAAGAGAATTGAA-Y  and  YTGTCTTGTAACATT'ICAAAGG- 
AACC  C TGATCTAC T TCTACACAGGTTC TCTTAAC TTGATC -5'.  This 
ll3-bp DNA  was inserted into the Nhel-cut pSR~HMGal(NheA).  The 
modified sequence in this region reads: .  . . Thrllg(Gly)(Ser)(Arg)-His  26s 
....  Ghi3~  123 .....  where the residues indicated in paren- 
theses were engineered into the oligonucleotides to create a diagnostic Xbal 
restriction site and to maintain the reading frame. The desired mutations 
were confirmed by restriction analyses and DNA sequencing of the relevant 
regions. 
Transient expression of  HMGal and 
HMGal/Dins(A ) in COS Cells 
For metabolic labeling, sub-confluent COS cells, grown in 150 nun dishes 
in DME containing 5%  FCS, were transfected with 100 #g of wild-type 
pSRc~HMGai or pSRaHMGal/Dins(A) by the calcium phosphate precipita- 
tion method (Graham and van der Eb, 1973).  In separate experiments we 
have established that maximal expression of ~-galactosidase activity of the 
chimeric proteins is reached 3 d after transfection. Two days after transfec- 
tion, the cells were refed with Induction Medium. On the third day, the cells 
were switched to methionine-free  MEM containing 5 % LPS and compactin 
and mevalonate and starved for 1 h. Cells were then pulsed with 250 #Ci 
of Tran35S-label  (125  #Ci/ml) for 2 h  at 37"C.  Cells were washed three 
times in PBS and lysed and processed for immunoprecipitation, as previ- 
ously described (Chnn et al.,  1990). 
For immunofluorescence studies, COS cells were plated on glass cover- 
slips in 60-mm dishes and transfected with plasmid DN~s, as described 
above. On the second day posttransfection, the coverslips were removed and 
inserted to individual wells of 24-well dishes and the cells were refed with 
1  ml  of Induction  Medium.  On  the third  day,  cells  were  washed and 
processed for immunofluorescence inspection. 
Immunogold Cytochemistry 
Rats, adapted to 12 h dark/12 h light cycle, were fed ad libitum powdered 
chow containing 5 % (wt/wt) cholestyramine resin. After 5 d, the diet was 
switched to chow containing 5% (wt/wt) cholestyramine and 0.2% (wt/wt) 
compactin for an additional 2 d. This diet regimen has been shown to in- 
crease hepatic levels of HMG-CoA reductase (Tanaka  et ai.,  1982;  Clark 
et al., 1984).  Near the end of the dark cycle, the animals were anesthetized 
with ether and their livers perfused in situ with saline then with fixative so- 
lution  (0.1% glutaraidehyde/0.2%  picric  acid/0.5  mM  CaC12 in  0.1  M 
NaPO4,  pH 7.4).  Portions of the liver, minced into  1 mm  3 cubes, were 
postfixed for an additional 4 h. The cubes were washed, stained en bloc with 
uranyl acetate, dehydrated, and embedded in LRGold, as described by Ber- 
ryman and Rodewald (1990).  Immunocytochemical localization of the G 
and H epitopes was done following procedures outlined by Berryman and 
Rodewald to enhance cell membrane contrast (Berryman and Rodewald, 
1990).  Briefly, ultra-thin sections of embedded tissue were incubated over- 
night with the primary antibodies diluted in 5 % normal goat serum in TBS. 
After washes, the sections were incubated with goat anti-rabbit IgG con- 
jngated to 5 nm colloidal gold, postfixed with 2% glutaraldehyde and 2% 
osmium tetroxide, and then stained with lead citrate. 
Results 
Antibodies against Peptides in the Membrane Domain 
of HMG-CoA Reductase 
The current topological model for the membrane domain of 
hamster HMG-CoA reductase,  schematically  drawn in Fig. 
1 A, is based on hydropathy plots of the amino acid sequence 
of the NH2-terminal 350 residues (Liscum et al.,  1985). An 
alternative model, which has recently emerged from our lab- 
oratory  (Olender and Simoni,  1992),  is depicted  in Fig.  1 
B. The major difference between the two models is the exis- 
tence of an additional membrane span between the putative 
6th and 7th spans of the original model, increasing the total 
number of spans to 8, and thereby reversing the orientation 
of spans  1-6 (Olender  and Simoni,  1992). 
To test the 8-span model by an independent approach, we 
prepared antibodies  against  synthetic peptides  correspond- 
ing to several  regions  in the membrane domain of HMG- 
CoA reductase.  The peptides  were coupled to PPD which 
elicits a strong immune response, yet does not give rise to 
antibodies against itself (Lachmann et al., 1986). Out of four 
different  peptides  injected,  only two anti-peptide  antisera 
recognized HMG-CoA reductase  in cells  (see below),  al- 
though all antibodies  recognized their respective  antigenic 
peptides in ELISA (data not shown). The peptides that pro- 
duced  anti-reductase  antibodies  correspond  to  residues 
Arg  TM  through  Leu  u2  in  loop  G  (H2N-RESREGRP1WQ- 
LSHFARVL-COOH,  peptide  G; Fig.  1 B) and to residues 
Thr  TM  through Glu  3~  in loop H  (H~N-TEHSKVSLGLDE- 
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DVSKRIE-COOH,  peptide H;  Fig.  1 B)  in the  sequence 
of both Chinese and Syrian hamster HMG-CoA reductase 
(Chin et al., 1984; Skalnik and Simoni, 1985). The antibod- 
ies produced are designated anti-G and anti-H, respectively. 
Both anti-G (Fig. 2, lane/) or anti-H (Fig. 2, lane 3) im- 
munoprecipitate  two  proteins  of M,  97,000  and  150,000 
from 3sS-labeled  CHO-HMGal lysates.  The mobilities of 
Figure 2. Specificity of  anti-G and anti-H antibodies. CHO-HMGal 
cells were grown in Induction Medium for 24 h before the experi- 
ment. Cells were starved for 1 h in methionine-free MEM and then 
labeled for 4 h with 150 ~Ci of [35S]methionine (0.5 mCi/ml; 0.3 
ml). Cells were washed and lysed, as described (Chun et al., 1990). 
After centrifugation, the cleared post-nuclear lysate was divided to 
five equal aliquots and 5/d of anti-G (lanes I and 2), anti-H (lanes 
3 and 4) IgGs or a 1:1 mixture of anti-reductase and anti-/3-galac- 
tosidase (lane 5) antibodies were added. For peptide competition, 
50/~g of free peptide G (lane 2) or peptide H (lane 4) were added 
to the cell lysate. Immunoprecipitation was carded out as described 
(Chun et al.,  1990), and precipitates were resolved by 8% SDS- 
PAGE. Relative molecular weight standards are indicated on the 
fight hand side. HMGR, HMG-CoA reductase and HMGal, the fu- 
sion protein between the membrane domain of HMG-CoA reduc- 
tase and/3-galactosidase,  are indicated by arrowheads. 
these bands  in  SDS  gels  are consistent with the  sizes  of 
HMG-CoA reductase (97 kD; Hardeman et al.,  1983; Chin 
et al.,  1984;  Skalnik and Simoni,  1985) and HMGal (150 
kD; Skalnik et al.,  1988). These proteins were specifically 
precipitated as they were competed by an excess of the corre- 
sponding free peptides (Fig. 2, lanes 2 and 4). Furthermore, 
the same proteins were precipitated with a mixture of anti- 
bodies directed against/~-galactosidase and the cytoplasmic 
domain of HMG-CoA reductase (Fig. 2, lane 5). The latter 
antibody mixture,  unlike the anti-peptide antibodies,  also 
precipitated  a  ,~63-kD  protein  (Fig.  2),  most  likely  the 
cytoplasm-facing proteolytic fragment of HMG-CoA reduc- 
tase (Hardeman et al.,  1983; Liscum et al.,  1985). 
To demonstrate unequivocally that the anti-peptide anti- 
bodies react with HMG-CoA reductase and HMGal, we car- 
ried out an immunodepletion experiment in which 35S-la- 
beled lysates of CHO-HMGal cells were first incubated with 
one antibody followed by removal of the immune complex. 
The supernatant solution was then taken through a  second 
round of immunoprecipitation with a different antibody (Fig. 
3). When pre-immune sera were used in the first round of 
precipitation (Fig. 3 A, lanes I and 9), anti-G and anti-H pre- 
cipitated the 97- and 150-kD proteins in the second precipi- 
tation step (Fig. 3 A, lanes 2 and 10, respectively). When the 
lysate was first treated with anti-G (Fig. 3 A, lanes 3, 5, and 
7), neither bands were precipitated in the second step with 
either anti-H (Fig. 3 A, lane 4), anti-HMG-CoA reductase 
(Fig. 3 A, lane 6), or anti-/3-galactosidase antibodies (Fig. 
3  A,  lane  8).  Conversely,  immunoprecipitation  with  the 
anti-H antibody (Fig. 3 A, lanes 11, 13, and 15) depleted the 
lysate of the 97- and 150-kD proteins, such that they could 
not be further immunoprecipitated by either anti-G (Fig. 3 
A, lane 12), anti-HMG-CoA reductase (Fig. 2 A, lane 14), 
or anti-/3-galactosidase (Fig. 3 A, lane 16).  In Fig. 3 B it is 
demonstrated  that  initial  immunoprecipitations  with  anti- 
HMG-CoA reductase (Fig. 3 B, lanes 3 and 9) or with anti-/5- 
galactosidase (Fig.  3 B,  lanes 5  and 1/) antibodies do not 
allow the  subsequent precipitation of the 97- and  150-kD 
proteins by either anti-G (Fig. 3 B, lanes 4 and 6) or anti-H 
(Fig. 3 B, lanes 10 and 12) antibodies, respectively. It should 
be noted that anti-HMG-CoA reductase antibody also im- 
munoprecipitates HMGal (Fig.  3  B,  lanes  3  and  9).  This 
polyclonal antibody was raised against the purified 52-kD 
cytoplasmic  fragment  of rat  liver  HMG-CoA  reductase 
(Jenke et al.,  1981) which has been recently shown to be 
generated by proteolysis at Ser  423 of the hamster sequence 
(Clarke  and  Hardie,  1990).  In  the  construction  of  the 
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antibodies  identify  the  same 
proteins in CHO-MHGal cells 
as do anti-HMG-CoA reduc- 
tase  or  anti-B-galactosidase 
antibodies. CHO-HMGal cells 
were grown, induced and la- 
beled with [35S]methionine  as 
described in the legend of  Fig. 
2. The cleared cell lysate was 
divided to 14 aliquots and 5 #1 
of  IgG fraction were added, as 
follows: (lst Ab) Preimmune 
(PI) serum of rabbits injected 
with peptide G, lanes 1 and 2 
in A and B);  anti-peptide G 
(G), lanes 3-8 in A; preim- 
mune (PI) serum of  rabbits in- 
jected with peptide H, A, lanes 
9and 10and B, lanes 7and 8; 
anti-peptide  H  (H),  lanes 
11-16 in A;  Anti-HMG-CoA 
reductase antiserum (Red), B, 
lanes 3, 4, 9, and 10; anti43- 
galactosidase antibody (Gal), 
B, lanes 5, 6, H, and 12. After 
incubation overnight at 4~ 
Protein A bacterial adsorbent 
was added aed further  incubated 
for 2 h at 4~  The tubes were 
spun at 16,000 g for 10 rain, 
the supernatants were carefi~y transferred into new tubes and were either analyzed by SDS-PAGE  or supplemented with different antibod- 
ies, as follows: (2ndAb): Anti-G, A, lanes 2 and 12 and B, lanes 2, 4, and 6; anti-H, A, lanes 4 and 10 and B, lanes 8, 10, and 12; 
anti-HMG-CoA reductase, A, lanes 6 and 14; anti-B-galactosidase, A, lanes 8 and 16. The second immunoprecipitation step was carried 
out overnight at 4~  followed by addition of Protein A bacterial adsorbent, as described above. All immunoprecipitates were processed 
and resolved simultaneously by 8 % SDS-PAGE. Relative molecular weight standard is indicated on the right hand side. HMG-CoA reduc- 
tase (HMGR) and HMGal (HMGal) are indicated by the arrowheads. 
HMGal chimera, B-galactosidase was cloned at position 449 
in the hamster reductase sequence (Skalnik et al.,  1988), 
therefore this anti-HMG-CoA reductase polyclonal antibody 
most likely reacts also with the region between Ser  .23 and 
Gln  44~ in HMGal. 
These results demonstrate that the 97- and  150-kD pro- 
teins correspond to HMG-CoA reductase and HMGal, re- 
spectively, and that anti-G and anti-H antibodies specifically 
recognize the membrane domain of these proteins. 
Anti-G and Anti-H Stain ER 
By indirect immunofluorescence (Fig. 4, A-F), anti-G (C), 
and anti-H (E) stain fixed and Triton X-100-permeabilized 
C100 cells in a manner indistinguishable from the staining 
obtained with either polyclonal (A) or mAbs (B) directed 
against  the  cytoplasmic domain of HMG-CoA reductase. 
C100 cells are a variant of an SV-40-transformed BHK cell 
line which was adapted to grow in the presence of 225 #M 
compactin. As a result, these cells exhibit some 100-fold in- 
creased  HMG-CoA  reductase  activity  (Hardeman  et  al., 
1983).  Anti-G and anti-H,  as well as the anti-HMG-CoA 
reductase antibodies, stain the nuclear envelope and a peri- 
nuclear reticulum of C100 cells. Associated with this reticu- 
lum and surrounding the nucleus are numerous intensely la- 
beled inclusions resembling the appearance of crystalloid 
ER in UT-1 cells (Chin et al.,  1982; Anderson et al.,  1983; 
Pathak et al.,  1986).  The binding of anti-G or anti-H is 
specific since it could be blocked by an excess of the corre- 
sponding antigenic peptides (Fig. 4, D and F, respectively). 
Additionally, the images in Fig. 4  G show that in CHO- 
HMGal cells, staining with anti-B-galactosidase antibodies 
also reveals a lacy structure throughout the cytoplasm, char- 
acteristic  of ER,  with  occasional  staining  of the  nuclear 
envelope. Associated with the ER are also several regions of 
intense fluorescence that  surround or appear on opposite 
sides of the nucleus (Fig. 4 G), similar to the ones observed 
in C100 cells. The A9 monoclonal anti-reductase antibody 
identifies the same structures in CHO-HMGal cells (Fig. 4 
H), indicating that HMGal and HMG-CoA reductase are co- 
localized in the same intracellular membranes. It should be 
noted that CHO-HMGal cells have been taken through sev- 
eral rounds of fluorescence-activated cell sorting to isolate 
population of cells expressing high HMGal activity (Chun et 
al., 1990). Thus, the elevated levels of HMGal in these cells 
may have caused proliferation of the ER similar to that ob- 
served in cells that express high levels of HMG-CoA reduc- 
tase (Chin et al.,  1982). 
G Epitope Faces the Cytoplasm in Cultured Cells and 
in Rat Liver 
To determine the sidedness of  the binding of  anti-G and anti-H 
antibodies to the membrane domain of HMGal/HMG-CoA 
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ing  the  plasma  membrane  without  compromising  the  in- 
tegrity of the ER (see Materials and Methods). 
Digitonin  Permeabilization.  Fixed  CHO-HMGal  cells 
were permeabilized  with  low concentrations  of digitonin. 
Digitonin,  which complexes with B-hydroxysterols, should 
perforate  preferentially  (but  not  exclusively)  the  plasma 
membrane because of its high content (~90%) of cellular 
free cholesterol (Lange, 1991). The permeabilized cells were 
stained simultaneously with mouse monoclonal anti-B-ga- 
lactosidase antibody and with rabbit anti-G or anti-H  an- 
tipeptide antibodies, followed by species-specific fluorescent 
secondary antibodies.  Inasmuch  as anti-H antibody reacts 
with a lumenal epitope adjacent to the single N-glycosylation 
site of HMG-CoA reductase (Liscum et al.,  1983b; Brown 
and Simoni,  1984) or HMGal (Skalnik et al., 1988; Olender 
and Simoni,  1992), this antibody should not gain access to 
its  epitope  when  the  ER  membrane  remains  intact.  The 
mouse antibody, which reacts with the cytoplasmically dis- 
posed/3-galactosidase domain of HMGal, serves as a control 
for accessibility of antibodies to the cell interior. Mild treat- 
ment with digitonin (5-10 #g/ml) allows staining of HMGal 
by  the  anti-/3-galactosidase  antibody,  with  no  significant 
binding of anti-H antibody to the membrane domain of the 
enzyme (Fig. 5, C and D). A and B of Fig. 5 show that, in 
cells which are first permeabilized with digitonin and then 
treated with Triton X-100, anti-H stains the same intracellu- 
lar structures as does anti-/~-galactosidase antibody, demon- 
strating  that the inability of anti-H to stain the cells in D 
is because of inaccessibility of the antibody to its cognate 
epitope in the lumen of the ER (see below). Anti-G antibody, 
on the other hand,  recognizes HMGal in digitonin-perme- 
abilized cells (Fig.  5 F) as effectively as it does in Triton 
X-100-treated  cells (Fig.  5  H),  and  stains  the  ER as in- 
tensely as does anti-~-galactosidase antibody (Fig. 5, E and 
G). These results demonstrate that, under conditions where 
lumenal epitopes are inaccessible to antibodies, the G epi- 
tope is readily exposed to antibodies in the cytoplasm. Simi- 
lar differential staining with anti-H and anti-G in digitonin- 
permeabilized  CHO-HMGal cells was obtained  when  we 
used the TUB2.1 monoclonal anti-~-tubulin antibody to as- 
sess accessibility to cytoplasmic epitopes (data not shown). 
To rule out the remote possibility that the antigenicity of 
the G or H epitopes in the membrane domain of HMG-CoA 
reductase/HMGal has been altered by digitonin, we used al- 
ternative  protocols  for  selective  permeabilization  of the 
plasma membrane. 
Permeabilization  by Streptolysin O. Streptolysin O (SLO), 
a pore-forming toxin produced by hemolytic streptococcus, 
was successfully used for selective permeabilization of the 
plasma membrane (Ahnert-Hilger et al.,  1989). We applied 
reduced SLO to fixed CHO-HMGal cells at 0~  After re- 
moving excess toxin,  the cells were warmed to 37~  and 
processed for immunofluorescent analysis, as described un- 
der Materials and Methods. That pores large enough to allow 
passage of antibodies to the cytoplasmic compartment were 
generated is indicated by the specific staining by the anti-B- 
galactosidase antibody (Fig. 6, A and C). Under these con- 
ditions,  however, ER lumenal  epitopes remain  cryptic,  as 
indicated by lack of staining  by anti-H antibodies (Fig.  6 
B).  Nevertheless, the G epitope is fully exposed to anti-G 
antibodies,  as demonstrated by the fluorescent labeling of 
the  same  structures  that  house  HMGal  (Fig.  6,  compare 
D  with C). 
Semi-intact Cells.  CHO-HMGal cells, grown on plastic 
dishes, were rendered semi-intact by the nitrocellulose over- 
lay method, essentially as described by Beckers et al. (1987). 
By this method large perforations are created in the cell sur- 
face when portions of the plasma membrane are peeled away 
by an overlaid nitrocellulose filter. Such large pores allow di- 
rect access of antibodies to the cytoplasmic domain of the 
cell (Beckers et al., 1987). In Fig. 6 we show that antibodies 
did indeed gain access to the cytoplasm of the semi-intact 
CHO-HMGal cells, as indicated by the staining of HMGal 
by anti-/%galactosidase antibody (Fig. 6, E and G). That the 
integrity of the ER membrane was maintained  is indicated 
by the lack of specific staining by anti-H antibody (Fig. 6 
F). Again, the G epitope was cytoplasmically accessible to 
anti-G antibody (Fig.  6 H). 
Rat Liver. Next, we examined the membrane sidedness of 
the G and H epitopes in situ by immunogold labeling of rat 
liver sections with the anti-peptide antibodies (Fig. 7). Both 
anti-G and anti-H antibodies label almost exclusively smooth 
tubules  and  vesicles of variable  sizes and  shapes  located 
throughout the cell. Labeling was not present over mitochon- 
dria, peroxisomes, nuclei, or Golgi cisternae, but was found 
over some regions of rough ER (not shown).  When using 
anti-G antibody, labeling is restricted to the cytoplasmic sur- 
faces of these vesicles (Fig. 7 A). Contrary, the epitope rec- 
ognized by anti-H antibody is found almost exclusively on 
the lumenal surfaces (Fig. 7 B). Thus, the results obtained 
from rat liver are consistent with those observed in cultured 
cells,  demonstrating  that epitope G  faces the cytoplasmic 
surface of the ER. 
The Loop Region between the 3rd and 4th Membrane 
Spans Is Lumenal 
The results presented above demonstrate that the G epitope 
is exposed to the cytoplasm whereas the H  epitope is lu- 
menal, indicating that the G and H epitopes are separated by 
a membrane spanning segment (see Fig. 1 B). This is in con- 
trast  to the  current  topological  model  for the  membrane 
spanning domain of HMG-CoA reductase in which both epi- 
topes reside in the lumen of the ER (Liscttm et al.,  1985; 
see Fig. 1 A). Moreover, these data strongly suggest that the 
l~gure 4. Anti-G and anti-H antibodies specifically identify endoplasmic reticulum in C100 and CHO-HMGal ceils. CIO0 (A-F) or CHO- 
HMGal (G and H) cells, grown on glass coverslips, were fixed and permeabilized with 0.25% Triton 3[-100, as described under Materials 
and Methods. C100 cells were stained with polyelonal rabbit anti-rat HMG-CoA reduetase antibodies (.4) or with the A9 mouse anti-hamster 
HMG-CoA reductase mAb (B). Cells were stained with anti-G antibody with (D) or without (C) 50 #g of competing peptide G, or with 
anti-H antibody with (F) or without (E) 50 #g of competing peptide H. CHO-HMGal cells were stained simultaneously with rabbit anti- 
/3-galactosidase antibodies (G, FITC-labeled secondary antibody) or with the A9 antibody (H, rhodamine-labeled secondary antibody). 
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tope G are reversed relative to the plane of the ER mem- 
brane. To test this directly, we deleted the H epitope from 
its native position between the glycosylation site and the last 
membrane span, and moved it into the loop region bridging 
spans three and four (see scheme in Fig. 8, bottom). Accord- 
ing to the seven spans model, this epitope should be exposed 
to the cytoplasm. COS cells were transfected with pcDLSRct 
plasmid  carrying this  mutated HMGal/Dins(A)  chimeric 
gene. In parallel, we transfected COS cells with the wild- 
type pSRczHMGal. Fig. 8 shows that HMGal/Dins(A) is ex- 
pressed in amounts comparable to those of wild type HMGal 
(compare lanes I and 4). Moreover, both anti-G (lanes 2 and 
5), and anti-H 0ones 3 and 6) antibodies precipitate the mu- 
tant and the wild type HMGal. These results suggest that the 
mutation in HMGal/Dins(A) does not grossly affect its rec- 
ognition by antibodies or stability. (The higher molecular 
size of HMGal/Dins(A) is expected due to the fact that a net 
of 20 residues were added to the protein (see Materials and 
Methods). 
Next,  the  plasma  membrane  of  the  cells  expressing 
HMGal/Dins(A) was selectively permeabilized with SLO, or 
cells were fully permeabilized with Triton X-100. The cells 
were immunofluorescently stained with a mixture of anti- 
/3-galactosidase  and  anti-H  antibodies  (Fig.  9).  Clearly, 
while the H epitope was fully accessible to anti-H antibodies 
in Triton X-100-permeabilized cells (Fig. 9 F), this epitope 
was not recognized in SLO-permeabilized HMGal/Dins(A) 
cells (Fig. 9 D), demonstrating that the H epitope in its al- 
tered position is still sequestered in the lumen of the ER, just 
as it is in its native position (Fig. 9 B). Taken together with 
our recent finding that a similar mutant, HMGal/Dins(-), is 
glycosylated in  vivo  (Olender  and  Simoni,  1992),  these 
results demonstrate that the loop region between the putative 
3rd and 4th membrane spans is lumenally disposed. 
The Sequence between the G and the H Epitopes 
Is Involved in the Sterol-accelerated Degradation 
of HMGal 
The results presented above demonstrate that the G and the 
H epitopes are separated by a transmembrane-spanning re- 
gion. Since the membrane domain of HMG-CoA reductase 
plays a critical role in the turnover of HMG-CoA reductase 
and of HMGal, we compared the regulated degradation of 
a  mutant in  which this putative transmembrane  segment 
(Gin  TM through Trp  273) has been replaced with the first trans- 
membrane span of bacteriorhodopsin (Span7-HMGal;  Chun 
and Simoni, 1992).  Fig.  10 shows that the B-galactosidase 
activity of wild type HMGal rapidly drops to '~25-30% of 
initial activity within 24 h after addition of excess sterols to 
CHO-HMGal cells. We have previously shown that this drop 
in activity is a result of accelerated degradation of HMGal 
(Skalnik et al., 1988; Chun et al., 1990; Inoue et al., 1991; 
Roitelman et al., 1991). The Span7-HMGal mutant, however, 
is totally unresponsive to added sterols (Fig. 10), indicating 
that the sequence between Gin  25' and Trp  273 is critical for 
the sterol-accelerated degradation of HMG-CoA reductase. 
Discussion 
In this report, we undertook an immunological approach to 
study the topology of  the membrane domain of  the ER glyco- 
protein HMG-CoA reductase, the rate-limiting enzyme in 
the cholesterogenic pathway. Such an approach has proven 
successful in studies of the topology of several membrane 
proteins (reviewed by Jennings, 1989). 
We describe the generation and characterization of mono- 
specific rabbit antibodies against synthetic peptides derived 
from the membrane-bound domain of HMG-CoA reductase. 
Using these antibodies, we demonstrate that the sequences 
Arg224-Leu  u2 and Thr~-Glu  3~  are on opposite sides of the 
ER membrane both in cultured CHO cells and in rat liver. 
We find that the region Arg224-Leu  242 (peptide G) faces the 
cytoplasm whereas peptide H (Thr284-Glu3~  resides, as ex- 
pected from its proximity to the native N-glycosylation site, 
in the lumen of  the ER. These results indicate that a sequence 
between Leu  242 and Thr  2u in the primary structure of ham- 
ster HMG-CoA reductase constitutes a previously unrecog- 
nized membrane spanning segment of the enzyme. This re- 
gion, which appears as a minor spike in hydropathy plots of 
HMG-CoA reductase amino acid sequences from many spe- 
cies (Liscum et al., 1985;  Skalnik and Simoni, 1985;  Raj- 
kovic et al.,  1989),  was interpreted to be a part of an ex- 
tended B-structure in the long lumenal loop that connects the 
putative 6th and 7th membrane spans in the model proposed 
by Liscum et al. (1985). 
We have recently shown that, in in vitro translation/trans- 
location assays, this sequence (hereafter referred to as span 
7,  see Figs.  1 B and  11) exhibits some signal recognition 
particle-independent membrane association and has  stop 
transfer  activity.  Also,  the  first  transmembrane  span  of 
HMG-CoA reductase (residues 1-39), which acts as the sig- 
nal sequence for the protein, assumes an N-cis orientation 
both in vitro and in vivo (Olender and Simoni, 1992). More- 
over,  mutants of HMGal in which the native glycosylation 
site was eliminated and a new glycosylation site has been in- 
troduced separately into loops B, D, or F (see Fig. 1 B) were 
all glycosylated in vivo, whereas sites at loops C, E, or G 
were not.  Taken together with the results presented here, 
these findings constitute evidence that the NH2 domain of 
HMG-CoA reductase spans the ER membrane eight times, 
as shown schematically in Fig. 11. Consequently, the mem- 
brane spanning regions NH2-terminal to span 7 are reversed 
in their orientation, relative to the plane of the ER mem- 
brane,  as compared to the 7  span model (Liscum et al., 
1985).  We tested this conclusion directly using the mutant 
HMGal/Dins(A) in which the loop segment conn~ing mem- 
brane spans 3 and 4 was tagged with epitope H. The results 
Figure 5. Anti-G antibody recognizes cytoplasmic epitopes in digitonin-permeabilized  CHO-HMGal cells. CHO-HMGal cells were fixed 
and permeabilized with 10 #g/ml of digitonin, as described under Materials and Methods. In A, B, (7, and H, cells were further treated 
with 0.25% Triton X-100. Cells were doubly stained with a mixture of mouse anti-B-galactosidase (A, C, E, and G, rhodamine-labeled 
secondary antibodies) with either anti-H antibodies (B and D) or anti-G antibodies (F and H, FITC-labeled secondary antibodies). Each 
pair of panels was photographed with the same exposure time and prints were made with the same time and contrast values. 
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cells.  On Day  1,  subeonfluent  COS cells  were transfected  with 
pSRotHMGal or with pSRctHMGal/Dins(A)  plasmids,  as described 
in Materials  and Methods.  On Day 2, the medium was removed and 
replaced with Induction Medium. On Day 3, cells were starved for 
methionine  for 1 h and then labeled  with 250 #Ci of Trans35S-la  - 
bel (0.5 mCi/mi) for 2 h. Cells were lysed and processed for immu- 
noprecipitation using either anti-B-galactosidase  antibody 0anes 1 
and 4), anti-G (lanes 2 and 5), or anti-H 0anes 3 and 6) antibodies. 
Immunoprecipitates were resolved  by 5-15% SDS-PAGE.  Closed 
and open arrowheads indicate  HMG-CoA reductase and HMGal 
[or HMGal/Dins(A)],  respectively. The migration of the ~4C-labeled 
phosphorylase b molecular weight standard is indicated on the left. 
A schematic  structure of HMGal and HMGal/Dins(A) is drawn at 
the bottom. 
clearly show that in its new position epitope H is still cryptic 
in the ER lumen, in agreement with the 8 membrane spans 
model. 
The current analysis does not allow us to define the precise 
boundaries  of span  7.  It is  possible  that this  span  is  very 
short, as has been suggested for several membrane spans of 
the  o~  subunit  of the  E.  coli  F:F0-ATPase  (Lewis  et  al., 
Figure  7.  Immunogold cytochemical localization of the G and H 
epitopes  in rat liver sections.  LRGold-embedded ultra-thin  section 
of livers from rats fed a cholestyramine/compactin diet were incu- 
bated with anti-G (A) or anti-H (B) antibodies followed by goat anti- 
rabbit IgG conjugated to 5-nm colloidal  gold, as described under 
Materials  and Methods.  (A) Anti-G antibody routinely label the cy- 
toplasmic surfaces of  smooth tubules and vesicles (arrowheads).  (B) 
Labeling with anti-H antibody is localized  to the lumenal  surfaces 
of smooth tubules  and vesicles  (arrowheads).  M, mitochondrion; 
Go,  Golgi complex.  Bar, 0.2 #m. 
Figure 6.  Anti-G antibody recognizes cytoplasmic epitopes in streptolysin  O- or mechanically permeabilized CHO-HMGal cells.  CHO- 
HMGal cells were permeabilized with SLO (A-D) or by the nitrocellulose  overlay method (E-H), as described under Materials  and Meth- 
ods. Cells were doubly stained  with a mixture of mouse anti-/5-galactosidase  (A, (7, E, and G) with either anti-H (B and F) or anti-G 
antibody (D and H), as described in the legend to Fig. 5. Each pair of panels  was photographed with the same exposure  time and prints 
were made with the same time and contrast values. 
Roitelman et al. Topology of Membrane Domain of HMG-CoA Reductase  969 Figure 9. Sidedness of the H epitope in HMGal and HMGal/Dins(A)  expressed in COS cells. COS cells, grown on glass coverslips were 
transfected with the wild-type pSRc~HMGal  (A and B) or the mutant pSRtxHMGaI/Dins(A) (C-F) plasmids, as described under Materials 
and Methods. On the 3rd day, cells were permeabilized  with SLO (A-D) or with Triton X-100 E and F). The cells were doubly stained 
with anti-/3-galactosidase antibody (A, C, and E) and anti-H antibodies (B, D, and F), as described  in the legend to Fig. 5. Each pair 
of panels was photographed  with the same exposure time and prints were made with the same time and contrast  values. 
1990).  Indeed, a  stretch of 10 hydrophobic residues in this 
region (MetZ~s-Va1267) may agree with this possibility, if this 
core assumes an extended non-or-helical conformation. Such 
a membrane span would be flanked on both sides by a cluster 
of charged residues, consistent with the general structure of 
spanning regions of polytopic membrane proteins (Jennings, 
1989).  Alternatively, it is reasonable that the sequence be- 
tween prou9 or Val  252 and Ala  275 constitutes this 7th mem- 
brane span since it is preceded by the highly charged stretch 
￿9  .EEEENK-  and followed by a -DPSP..  , 5 residues NH2- 
terminal to the native glycosylation site at Asn  TM  (Fig.  11). 
This region of 24-27 residues is of sufficient length to span 
the ER membrane in an a-helical configuration and contains 
the  above mentioned  hydrophobic  core  of  10  contiguous 
amino acids.  In this  model,  however, there are  five basic 
residues buried in the lipid bilayer (Fig.  11) which  would 
make this segment the most charged span in the membrane 
domain of the protein. Yet, potentially charged residues also 
occur in other membrane segments of HMG-CoA reductase, 
regardless of the model proposed. 
It has been demonstrated that the membrane domain of the 
reductase is responsible for the regulated ER degradation of 
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Figure  1(2  Replacement  of 
transmembrane  Span 7  with 
the  first  membrane  span  of 
bacteriorhodopsin  abolishes 
the  sterol-accelerated  degra- 
dation of HMGal. The growth 
medium of CHO cells express- 
ing wild type HMGal (e) or 
Span 7-HNGal (i) (Chun and 
Simoni,  1992) was  switched 
to Induction Medium 24 h be- 
fore addition of sterols. A mix- 
ture of 25-hydroxycholesterol and cholesterol was given in ethanol 
(final concentration are 1.5/~g/ml and 15/~g/ml, respectively) in 
a staggered fashion, so that all time points could be assayed simul- 
taneously. The B-galactosidase  activity of  the chimeric proteins was 
assayed as previously described (Skalnik et al.,  1988). 
the enzyme and of HMGal (Gil et al.,  1985; Skalnik et al., 
1988; Chun et al., 1990). The results presented in this report 
demonstrate the role of span 7 in this level of enzyme regula- 
tion. Replacement of wild type span 7 with the first mem- 
brane span of bacteriorhodopsin creates an enzyme with a 
short half-life, --2 h  (Chun and Simoni,  1992; Roitelman 
and Simoni, unpublished results), and completely abolishes 
the sterol-accelerated ER degradation of HMGal. Interest- 
ingly, a  similar phenotype is created by deleting spans 4 
and 5 in the membrane domains of HMG-CoA reductase and 
HMGal (Jingami et al., 1987; Skalnik et al., 1988; Chun and 
Simoni, 1992). The replacement mutation, which introduces 
the sequence GWlWLALGTALMGLGTLYFLVKG  in place 
of residues Gin  2s through Trp  ~7a, does not disturb the intra- 
cellular  targeting  or  transmembrane  orientation  of span 
7-HMGal since the mutant enzyme is active and is localized 
correctly in the ER (Chun and Simoni, 1992). However, this 
replacement eliminates most of the charged residues in this 
segment.  Therefore, it is  attractive to  speculate that the 
charged residues in span 7 play a role in the sterol-regulated 
degradation of HMG-CoA reductase as they do in the ER 
degradation of the ot subunit of the T cell antigen receptor 
(Bonifacino et al., 1991; Bonifacino and Lippincott-Schwartz, 
1991). Possibly these residues are engaged in intramolecular 
charge interaction between adjacent membrane spans that 
might stabilize the enzyme or in intermolecular interactions 
involved in monomer-dimer interconversion between sub- 
units of the reductase (Edwards et al.,  1985;  Ness et al., 
1985; Roitelman and Shechter, 1986), similar to the associa- 
tion between subunits of  the T cell antigen receptor and CD3 
(Cosson et al.,  1991). Alternatively, membrane span 7 may 
interact directly with sterols or indirectly with an auxiliary 
protein(s) that tag HMG-CoA reductase for degradation in 
response to sterols. 
Liscum et al.  have noted that in HMG-CoA reductase 
gene, as in the bovine rhodopsin gene (Nathans and Hog- 
hess,  1983), the introns are located near the junction of a 
membrane span and an external loop, such that each mem- 
brane span is separated from the adjacent span by a single 
intron (Liscum et al., 1985). The position of intron 8 of the 
reductase gene (Reynolds et al.,  1984) in span 7 conforms 
with this general relation between gene organization and pro- 
tein structure (Fig.  11). 
HMG-CoA reductase and HMGal,  large proteins of M, 
>1100,000, are rapidly degraded in the ER when sterols or 
mevalonate are added to the cells. The degradation pathway 
undertaken by these proteins, and the fate of the polypeptide 
chains during proteolysis is unknown. No degradation inter- 
mediates  have been  detected  in  pulse-chase  experiments 
when immunoprecipitation was performed with antibodies 
directed against the cytoplasmic domains of reductase or of 
HMGal. Hence, detection and identification of such proteo- 
lyric fragments is essential for elucidating the process of 
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Figure I1. Proposed model for 
the orientation  of the  trans- 
membrane  spans of  HMG-CoA 
reductase.  Amino acids resi- 
dues are shown in the single- 
letter code. Charged residues 
am shaded. Residues that po- 
tentially mark the boundaries 
of membrane spans are num- 
bered. S~luences  comprising 
peptides G and H are circled. 
The N-glycosylation site is in- 
dicated by an asterisk.  Possi- 
ble boundaries of Span 7 are 
dashed and the core of 10 hy- 
drophobic amino acids in this 
span  is  boxed.  Intron-exon 
boundaries  are  indicated  by 
arrowheads. 
Roitelman et al. Topology of Membrane Domain of HMG-CoA Reductase  971 regulated ER degradation.  We anticipate that the antibodies 
against the membrane domain described  in this report will 
prove useful also towards this goal. 
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